Search Videos and More
How Air Pollution Accelerates Alzheimer’s Disease
Investigators from the Department of Neurosurgery at Cedars-Sinai have determined that exposure to polluted air could accelerate development of Alzheimer’s disease in those with genetic risk factors for the neurodegenerative condition.Rare-Disease Specialist Joins Cedars-Sinai Movement Disorders Program
Yvette Bordelon, MD, PhD, Treats Patients With Huntington’s Disease and Rare Forms of Parkinson’s Disease, Works on Related Clinical TrialsA Stent—And No Stroke—For This Patient
Cedars-Sinai Neurosurgeons Use Minimally Invasive, State-of-the-Art Stenting to Restore Blood Flow to the Brain, Preventing a Debilitating StrokeTreating Pituitary Apoplexy: Medical Management Versus Surgery
Multicenter International Study, Led by Cedars-Sinai, Finds Medical Management Yields Similar Results to SurgeryCedars-Sinai Neurology Chair Honored by National MS Society for COVID-19 Work
Early in the pandemic, patients with multiple sclerosis (MS), an autoimmune disease, were thought to possibly be at higher-than-average risk for COVID-19.The IX Cedars-Sinai Parkinson's Disease and Movement Disorders Annual Symposium
Saturday, October 21, 2023, 7:30 AM - 4:00 PM, The Shay, 8801 Washington Blvd, Culver City, CAUpdates in Rehabilitation for Neurodegenerative Conditions
Saturday, October 14, 2023, 7:15 AM - 3:05 PM, Cedars-Sinai Medical Center, Los Angeles, CA21st Annual Emergency Medicine Symposium: A Practical Update
Friday, December 8, 2023, 7:15 AM - 5:00 PM, Four Seasons Hotel Los Angeles at Beverly Hills, 300 South Doheny Drive, Beverly Hills, CAUnlocking the Brain’s Stress-Eating Connection
Cedars-Sinai Investigators Identify a Brain Circuit in Mice That Suppresses Feeding and Boosts Energy Expenditure in Response to Stress—Especially in FemalesCan a Blood Test Detect Alzheimer’s Disease?
Memory Expert Zaldy Tan, MD, Talks About New Blood Tests Hitting the Market, What They Measure and Who Should—or Shouldn’t—Take ThemCedars-Sinai Once Again Ranked in Top Tier of U.S. Hospitals
Medical Center Named to Honor Roll for Eighth Consecutive Year in U.S. News & World Report’s Annual “Best Hospitals” Analysis; Also Tied for #1 in California and Los Angeles, and Ranked Nationally in 11 Medical SpecialtiesCedars-Sinai Experts Discuss Pros, Cons of New Alzheimer’s Drug
Physicians Are Preparing to Offer Newly Approved Lecanemab to Treat Early-Stage Alzheimer’s Disease; Drug Requires Careful Patient Selection and Monitoring